ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Clinical trial NCT05400382 updates: 1. status: UNKNOWN → RECRUITING 2. start date: 2023-07-01 → 2025-12-01 3. completion date: 2026-03-31 → 2028-03-31 4. primary completion date: 2026-03-31 → 2028-03-31 5. primary purpose: TREATMENT → PREVENTION 6. collaborators added: University of Utah 7. collaborators removed: University of Pittsburgh Medical Center, Northwestern University Feinberg School of Medicine
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical